V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004370 | 280007536 | 1.54 | 57 | Curative (C) | 2015-04-11 | 2015-04-11 | CISPLATIN + GEMCITABINE | 2 | null | 280027217 | CISPLATIN + GEMCITABINE |
| 280004371 | 280007536 | 1.68 | 53.35 | Palliative (P) | 2013-05-09 | 2013-05-26 | Cetuximab 7 day (Cycle 1) | 2 | N | 280027217 | CETUXIMAB |
| 280004372 | 280003055 | 1.68 | 24.4 | Palliative (P) | 2017-04-09 | 2017-05-01 | Carboplatin AUC 6 - 10 | N | N | 280027221 | CARBOPLATIN |
| 280004373 | 280003056 | 1.68 | null | null | 2017-03-17 | 2017-04-11 | CARBOPLATIN | N | Y | 280027222 | CARBOPLATIN |
| 280004374 | 280003057 | 1.63 | 57 | Palliative (P) | 2013-08-25 | 2013-08-28 | CARBOPLATIN + RT | N | N | 280027225 | CARBOPLATIN + RT |
| 280004375 | 280003058 | null | 88.7 | Neo-adjuvant (N) | 2016-04-14 | 2016-05-06 | Carboplatin + Etoposide iv&po | 02 | N | 280027226 | CARBOPLATIN + ETOPOSIDE |
| 280004376 | 280003059 | 1.62 | 63.9 | Curative (C) | 2016-08-10 | 2016-08-17 | EOX | N | N | 280027227 | EOX |
| 280004377 | 280007537 | 1.79 | 74.2 | Curative (C) | 2015-07-20 | 2015-08-07 | Cetuximab 7 day (Cycle 1) | N | Y | 280027228 | CETUXIMAB |
| 280004378 | 280007537 | null | null | Curative (C) | 2013-05-01 | 2013-05-13 | EOX | N | N | 280027228 | EOX |
| 280004379 | 280007537 | 1.53 | null | Curative (C) | 2013-10-30 | 2013-11-06 | EOX | null | N | 280027228 | EOX |
| 280004380 | 280003060 | 1.66 | 82.4 | Palliative (P) | 2016-11-10 | 2016-11-25 | EOX | N | Y | 280027232 | EOX |
| 280004381 | 280003060 | 1.66 | 36.1 | Curative (C) | 2013-12-29 | 2013-12-30 | CARBOPLATIN + RT | 02 | N | 280027232 | CARBOPLATIN + RT |
| 280004382 | 280003060 | 1.72 | 88 | Curative (C) | 2016-10-10 | 2017-12-05 | CETUXIMAB | N | N | 280027232 | CETUXIMAB |
| 280004383 | 280003061 | 1.68 | 74.2 | Palliative (P) | 2017-07-14 | 2017-07-22 | CARBOPLATIN + PACLITAXEL | N | N | 280027242 | CARBOPLATIN + PACLITAXEL |
| 280004384 | 280003062 | 1.64 | 82.5 | Curative (C) | 2015-02-23 | 2015-03-09 | Cetuximab 7 day (Cycle 1) | Y | Y | 280027247 | CETUXIMAB |
| 280004385 | 280003063 | null | 79.1 | Curative (C) | 2015-11-13 | 2015-11-20 | CARBOPLATIN + ETOPOSIDE | null | N | 280027249 | CARBOPLATIN + ETOPOSIDE |
| 280004386 | 280003063 | 1.61 | 74.4 | Palliative (P) | 2017-08-21 | 2017-09-10 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280027249 | CISPLATIN + GEMCITABINE |
| 280004387 | 280003063 | 1.78 | 89.8 | Curative (C) | 2016-07-16 | 2016-07-16 | EOX | null | N | 280027249 | EOX |
| 280004388 | 280003064 | 1.6 | 50.5 | Curative (C) | 2016-06-16 | 2016-07-11 | CARBOPLATIN + RT | 02 | N | 280027253 | CARBOPLATIN + RT |
| 280004389 | 280003064 | 1.69 | null | Curative (C) | 2015-05-12 | 2015-05-15 | EOX | N | N | 280027253 | EOX |
| 280004390 | 280003064 | 1.76 | 72 | Curative (C) | 2014-03-19 | 2014-03-26 | EOX | N | Y | 280027253 | EOX |
| 280004391 | 280003064 | 0 | 94.9 | Neo-adjuvant (N) | 2016-05-30 | 2016-06-25 | CETUXIMAB | N | N | 280027253 | CETUXIMAB |
| 280004392 | 280003065 | 1.74 | 46.2 | Curative (C) | 2013-10-26 | 2013-10-30 | EOX | 02 | N | 280027268 | EOX |
| 280004393 | 280007541 | 1.83 | 14.3 | null | 2013-05-19 | 2013-05-21 | CARBOPLATIN + RT | N | Y | 280027270 | CARBOPLATIN + RT |
| 280004394 | 280003066 | 1.81 | 77.1 | Curative (C) | 2012-07-29 | 2013-07-28 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | Y | 280027273 | NOT MATCHED |
| 280004395 | 280007542 | 1.67 | null | Curative (C) | null | 2014-10-30 | Cetuximab 7 day (Cycle 1) | null | null | 280027276 | CETUXIMAB |
| 280004396 | 280003067 | null | 75.2 | Palliative (P) | 2014-05-27 | 2014-06-03 | Cetuximab 7 day (Cycle 1) | Y | N | 280027277 | CETUXIMAB |
| 280004397 | 280003067 | 1.57 | 67.1 | Curative (C) | 2015-10-22 | 2015-11-19 | Carboplatin AUC 6 - 10 | Y | N | 280027277 | CARBOPLATIN |
| 280004398 | 280003067 | 1.95 | 67.2 | null | 2015-12-20 | 2015-12-20 | Trial Unspecified | 02 | N | 280027277 | TRIAL |
| 280004399 | 280003068 | 1.79 | 74.1 | Curative (C) | null | 2016-08-14 | Trial Unspecified | N | N | 280027281 | TRIAL |
| 280004400 | 280007544 | 1.88 | 109.2 | Adjuvant (A) | 2017-09-27 | 2017-10-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027282 | CISPLATIN + GEMCITABINE |
| 280004401 | 280009847 | 1.72 | 82 | Palliative (P) | 2016-03-21 | 2016-03-23 | Trial Unspecified | N | Y | 280027285 | TRIAL |
| 280004402 | 280003069 | 1.65 | 55 | Neo-adjuvant (N) | 2017-01-27 | 2017-02-26 | Cetuximab 7 day (Cycle 1) | 02 | Y | 280027288 | CETUXIMAB |
| 280004403 | 280003069 | 1.9 | 129 | Curative (C) | 2016-08-22 | 2016-09-20 | Carboplatin AUC 6 - 10 | N | Y | 280027288 | CARBOPLATIN |
| 280004404 | 280003069 | 1.74 | 9.4 | Neo-adjuvant (N) | 2016-08-02 | 2016-08-04 | Carboplatin + Etoposide IV 3 day | N | N | 280027288 | CARBOPLATIN + ETOPOSIDE |
| 280004405 | 280003069 | 1.74 | null | Neo-adjuvant (N) | 2017-07-16 | 2017-07-22 | EW EuroEwing 2012 Arm B IE | null | null | 280027288 | TRIAL |
| 280004406 | 280003070 | 1.7 | 78.6 | Palliative (P) | null | 2016-06-30 | Carboplatin AUC 6 - 10 | 02 | null | 280027293 | CARBOPLATIN |
| 280004407 | 280003071 | 0 | 18.9 | Curative (C) | 2015-02-01 | 2015-02-02 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | null | 280027294 | NOT MATCHED |
| 280004408 | 280003071 | 1.6 | 65 | Curative (C) | 2015-05-17 | 2015-05-28 | Carboplatin AUC 2 - 5 | 2 | Y | 280027294 | CARBOPLATIN |
| 280004409 | 280003072 | 1.54 | 79.2 | Curative (C) | null | 2015-12-22 | CARBOPLATIN + PACLITAXEL | 02 | null | 280027296 | CARBOPLATIN + PACLITAXEL |
| 280004410 | 280007547 | 1.8 | null | Curative (C) | 2017-11-21 | 2017-11-27 | CARBOPLATIN + PACLITAXEL | 2 | N | 280027297 | CARBOPLATIN + PACLITAXEL |
| 280004411 | 280007547 | 1.63 | 82.4 | Curative (C) | 2017-01-26 | 2017-02-05 | CETUXIMAB | 2 | N | 280027297 | CETUXIMAB |
| 280004412 | 280007547 | null | 83.5 | null | 2018-02-26 | 2018-03-06 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280027297 | NOT MATCHED |
| 280004413 | 280007547 | null | 94.4 | Curative (C) | 2017-02-04 | 2017-02-07 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | Y | 280027297 | NOT MATCHED |
| 280004414 | 280007547 | 1.61 | 53.2 | null | 2018-05-04 | 2018-05-12 | Trial Unspecified | null | null | 280027297 | TRIAL |
| 280004415 | 280011969 | 1.6 | 50.5 | Curative (C) | 2015-10-11 | 2015-10-25 | Carboplatin AUC 2 - 5 | 02 | N | 280027308 | CARBOPLATIN |
| 280004416 | 280011969 | 1.64 | 81.8 | Curative (C) | 2017-01-31 | 2017-01-31 | CISPLATIN + GEMCITABINE | 02 | N | 280027308 | CISPLATIN + GEMCITABINE |
| 280004417 | 280012093 | 1.62 | 56 | Curative (C) | 2014-09-13 | 2014-10-12 | CETUXIMAB | N | N | 280027310 | CETUXIMAB |
| 280004418 | 280012093 | 1.56 | 51 | Curative (C) | 2013-12-29 | 2013-12-29 | EOX | N | null | 280027310 | EOX |
| 280004419 | 280003073 | null | 58.2 | Not known (9) | 2013-03-13 | 2013-04-08 | Carboplatin AUC 6 - 10 | 02 | Y | 280027312 | CARBOPLATIN |